Scientists used poly (lactic-co-glycolide) to co-encapsulate type 1 diabetes-relevant antigen and 3 distinct TREG-inducing molecules – rapamycin, all-trans retinoic acid, and butyrate – that targeted the mechanistic target of Rapa, the retinoid pathway, and histone deacetylase inhibition, respectively.
[Drug Delivery and Translational Research]
6445212
AAAAAAAA
items
1
apa
0
default
asc
1
167636
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/